TipRanks
Editas Medicine Inc (DE:8EM)
FRANKFURT:8EM
Germany Market
8EM
Editas Medicine
RESEARCH TOOLSreports

Editas Medicine (8EM) Income Statement

2 Followers

Editas Medicine Income Statement

Last quarter (Q2 2026), Editas Medicine's total revenue was $11.89M, an increase of 232.31% from the same quarter last year. In Q2, Editas Medicine's net income was $-18.23M. See Editas Medicine’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 40.52M$ 32.31M$ 78.12M$ 19.71M$ 25.54M
Gross Profit
$ 40.52M$ -166.93M$ 72.06M$ 13.38M$ 20.49M
Operating Expenses
$ 139.86M$ 84.22M$ 241.24M$ 239.32M$ 213.64M
Depreciation and Amortization
$ 5.28M$ 5.81M$ 6.06M$ 6.34M$ 5.05M
EBITDA
$ -148.61M$ -233.11M$ -147.16M$ -214.09M$ -187.45M
Operating Income
$ -99.34M$ -251.15M$ -169.18M$ -225.95M$ -193.15M
Other Income/Expenses
$ -60.72M$ 14.06M$ 15.96M$ 5.52M$ 644.00K
Pretax Income
$ -160.06M$ -237.09M$ -153.22M$ -220.43M$ -192.50M
Net Income
$ -160.06M$ -237.09M$ -153.22M$ -220.43M$ -192.50M
Per Share Metrics
Basic EPS
$ -1.80$ -2.88$ -2.02$ -3.21$ -2.85
Diluted EPS
$ -1.80$ -2.88$ -2.02$ -3.21$ -2.85
Weighted Average Shares Outstanding
 88.75M 82.34M 75.97M 68.66M 67.62M
Weighted Average Shares Outstanding (Diluted)
 88.75M 82.34M 75.97M 68.66M 67.62M
Currency in USD

Editas Medicine Earnings and Revenue History